We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Alnylam and Cubist Collaborates to Develop and Commercialize RNAi Therapeutics Targeting RSV Infection

News   Jan 12, 2009

 
Alnylam and Cubist Collaborates to Develop and Commercialize RNAi Therapeutics Targeting RSV Infection
 
 
 

RELATED ARTICLES

New Method to Synthesize and Screen Macrocyclic Compounds

News

Scientists at EPFL have found a way to generate libraries of more than 9,000 of macrocyclic molecules below 1 KDa, all with high structural diversity.

READ MORE

Pomegranate Juice During Pregnancy May Improve Brain Development

News

Clinical researchers are exploring whether pomegranate juice intake during pregnancy can have a protective effect. Now, researchers present their preliminary findings from a clinical trial of expectant mothers whose babies were diagnosed with intrauterine growth restriction (IUGR).

READ MORE

Lab-on-a-Chip Aids Search for Drugs to Prevent Blood Clots

News

A tiny lab the size of a postage stamp could be the next "big thing" in the search for safer anti-clotting drugs to prevent heart attacks and strokes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE